Literature DB >> 1789820

A standard heparin nomogram for the management of heparin therapy.

M K Cruickshank1, M N Levine, J Hirsh, R Roberts, M Siguenza.   

Abstract

A nomogram for the adjustment of heparin dosage was developed to standardize heparin therapy and to reduce delays in achieving and maintaining a therapeutic activated partial thromboplastin time (APTT) result. Fifty consecutive patients with acute venous thromboembolism had their continuous intravenous heparin therapy adjusted according to this heparin nomogram. The effect of the nomogram on heparin therapy in these patients was compared with data from 53 historical control patients. The proportion of patients in the nomogram group who reached a therapeutic APTT at 24 hours after the start of heparin therapy was 66%, which increased to 81% at 48 hours. In contrast, 37% and 58% of the control patients reached a therapeutic APTT at 24 and 48 hours, respectively. The percentage of therapeutic APTT results of the total number of APTT determinations was greater in the nomogram patients than controls. The use of this heparin nomogram resulted in (1) achieving a therapeutic APTT at 24 and 48 hours in a large proportion of patients and (2) reduced periods of inadequate anticoagulation and overanticoagulation during heparin therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1789820

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  35 in total

1.  Description and Evaluation of the Implementation of a Weight-Based, Nurse-Driven Heparin Nomogram in a Tertiary Academic Medical Center.

Authors:  James W Schurr; Craig A Stevens; Anne Bane; Carol Luppi; Sarah E Culbreth; Amy Leigh Miller; Jean M Connors; Katelyn W Sylvester
Journal:  Clin Appl Thromb Hemost       Date:  2017-08-04       Impact factor: 2.389

Review 2.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Standardization of clinical decision making for the conduct of credible clinical research in complicated medical environments.

Authors:  A H Morris; T D East; C J Wallace; M Franklin; L Heerman; T Kinder; M Sailor; D Carlson; R Bradshaw
Journal:  Proc AMIA Annu Fall Symp       Date:  1996

4.  Effectiveness of Unfractionated Heparin in Normal Saline versus Dextrose for Achieving and Maintaining Therapeutic Anti-Factor Xa Levels in Patients with Non-ST-Elevation Acute Coronary Syndrome.

Authors:  Amanda C Jacques; Colleen Lougheed; Erika Macdonald; Alan Karovitch; Pierre Giguère
Journal:  Can J Hosp Pharm       Date:  2013-11

5.  Patterns of paging medical interns during night calls at two teaching hospitals.

Authors:  R Harvey; P G Jarrett; K M Peltekian
Journal:  CMAJ       Date:  1994-08-01       Impact factor: 8.262

6.  Early reactivation of ischaemia after abrupt discontinuation of heparin in acute myocardial infarction.

Authors:  G Di Tano; A Mazzù
Journal:  Br Heart J       Date:  1995-08

7.  Delivery of optimized inpatient anticoagulation therapy: consensus statement from the anticoagulation forum.

Authors:  Edith A Nutescu; Ann K Wittkowsky; Allison Burnett; Geno J Merli; Jack E Ansell; David A Garcia
Journal:  Ann Pharmacother       Date:  2013-04-12       Impact factor: 3.154

8.  Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials.

Authors:  R Collins; S MacMahon; M Flather; C Baigent; L Remvig; S Mortensen; P Appleby; J Godwin; S Yusuf; R Peto
Journal:  BMJ       Date:  1996-09-14

9.  A data-driven approach to optimized medication dosing: a focus on heparin.

Authors:  Mohammad M Ghassemi; Stefan E Richter; Ifeoma M Eche; Tszyi W Chen; John Danziger; Leo A Celi
Journal:  Intensive Care Med       Date:  2014-08-05       Impact factor: 17.440

10.  Heparin anticoagulation responsiveness in a coronary care unit: a prospective observational study.

Authors:  Faisal Alsayegh; Mona Al-Rasheed; Ali Al-Muhaini; Ekhlas Al-Humoud; Mona Al-Ostaz; Shaker A Mousa
Journal:  Cardiovasc Ther       Date:  2009       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.